All Sauce from Weekly Sauce:

The first pill to treat adults with severe alopecia was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot, the agency said in a news release announcing the approval. “Access to safe and effective treatment options…  read on >  read on >

Stress may take a huge toll on your health, weakening your immune system and opening the door to serious illness, a new study suggests. Traumatic events, job strain, daily stressors and discrimination may all speed aging of the immune system, increasing the risk for cancer, heart disease and other illness, including COVID-19, researchers report. “New…  read on >  read on >

Despite worries that COVID-19 symptoms can return after patients take the drug Paxlovid, such cases of rebound symptoms are actually rare, a new study shows. In an advisory last month, the U.S. Centers for Disease Control and Prevention cautioned that COVID-19 can sometimes make a comeback after an infected person has gone through a round…  read on >  read on >

Bouncing on a trampoline is always risky, but kids are more likely to suffer serious injuries at a trampoline center than at home, according to researchers who are calling for mandatory safety standards at the centers. U.S. emergency departments treat nearly 100,000 children a year for trampoline injuries. The popularity of trampoline centers has soared…  read on >  read on >

Hot flashes are one of the most well-known symptoms of menopause and they can be severe and frequent, happening throughout the day and night over several years. Researchers say they have found a new, effective treatment that could provide relief and an alternative to existing therapies. “The simple truth is for many years, we did…  read on >  read on >

Yet another study shows that ivermectin provides no benefits for COVID-19 patients, but researchers say they’ll continue to study a higher dose of the drug. Even though the drug used for parasitic infections in animals and people is not approved by the U.S. Food and Drug Administration to treat COVID-19, some have touted it as…  read on >  read on >

An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035) calls for Massachusetts-based drug maker Amylyx Pharmaceuticals later to provide better evidence…  read on >  read on >